BioCeramic Therapeutics (United Kingdom) a development-stage provider of bioactive materials for orthopaedic and dental applications, closed a $1.9M Series B financing. Participants include Imperial Innovations, Longbow Capital Partners, Comvest and Esmee Fairbairn Foundation.
OnBioVC... http://ow.ly/YO41
Company Website... http://www.bioceramictherapeutics.com/...
